SEC Form 4 · accession 0001645470-19-000015
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Feb 22, 2019
Accepted (ET)
Feb 27, 2019 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2019 | P | 5,000 | $0.0227 | A | 21,608,123 | D | |
| Common Stock | Feb 22, 2019 | P | 10,000 | $0.0227 | A | 21,618,123 | D | |
| Common Stock | Feb 22, 2019 | P | 4,000 | $0.0228 | A | 21,622,123 | D | |
| Common Stock | Feb 22, 2019 | P | 1,000 | $0.0226 | A | 21,623,123 | D | |
| Common Stock | Feb 22, 2019 | P | 5,000 | $0.0229 | A | 21,628,123 | D | |
| Common Stock | Feb 25, 2019 | P | 5,000 | $0.022 | A | 21,633,123 | D | |
| Common Stock | Feb 26, 2019 | P | 5,000 | $0.0209 | A | 21,638,123 | D | |
| Common Stock | Feb 26, 2019 | P | 5,000 | $0.0212 | A | 21,643,123 | D |
Table II — derivative securities
No Table II lines on this filing.